Product Information
CAPECITABINE 150 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.3615 per EA under NDC 68001064306. Its NADAC has been published 60 times since May 7, 2025.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001064306
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA210203On Market Since
4/18/2025
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 150 MG TABLET has been published 60 times since May 7, 2025, and over the history we have for it it has risen 56.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3615 per EA |
|---|---|
| All-time high | $0.4038 (Sep 10, 2025) |
| All-time low | $0.2313 (May 7, 2025) |
| 52-week high | $0.4038 |
| 52-week low | $0.3615 |
| Median price | $0.3955 |
| Average price | $0.3761 |
| Largest weekly change | +31.0% (May 21, 2025) |
| Weeks tracked | 60 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPECITABINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by BluePoint Laboratories, is $0.3615 per EA (NDC 68001064306), effective Jun 24, 2026.
How has the price of CAPECITABINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has risen 56.3%. It has been tracked across 60 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?
Since May 7, 2025, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2313 (May 7, 2025) to a high of $0.4038 (Sep 10, 2025), with a median of $0.3955 per EA.
Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CAPECITABINE 150 MG TABLET, but none are currently priced below it.
Who manufactures CAPECITABINE 150 MG TABLET?
CAPECITABINE 150 MG TABLET (NDC 68001064306) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification